The global market for Needle-free Injection Systems was valued at US$ 221 million in the year 2024 and is projected to reach a revised size of US$ 311 million by 2031, growing at a CAGR of 5.1% during the forecast period.
Needle-free Injection Device is a type of medical injecting syringe that uses a high-pressure narrow jet of the injection liquid instead of a hypodermic needle to penetrate the epidermis. It is powered by compressed air or gas, either by a pressure hose from a large cylinder, or form a built-in gas cartridge, small cylinder, or spring.
Needle-free injection systems are novel ways to introduce various medicines into patients without piercing the skin with a conventional needle. It was developed to reduce the number of needle stick accidents and associated problems.
Global Needle-free Injection Systems main manufactuers Antares Pharma, Endo International plc and Inovio Pharmaceuticals, which totally accounts for the 65% of the market. As for the types of products, it can be divided into Powder Injections, Liquid Injections and Depot or Projectile Injection. In terms of application, it is widely used in SVaccine Delivery, Insulin Delivery and Others. The most common application is Insulin Delivery, with a share over 56%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Needle-free Injection Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Needle-free Injection Systems.
The Needle-free Injection Systems market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Needle-free Injection Systems market comprehensively. Regional market sizes, concerning products by Power, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Needle-free Injection Systems manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Power, by Application, and by regions.
By Company
Antares Pharma
Endo International plc
Inovio Pharmaceuticals
Injex Pharma
National Medical Products Inc (J-Tip)
Recipharm
European Pharma Group (InsuJet)
Miracle Medical
Medical International Technology (MIT)
Akra Dermojet
PharmaJet
Portal Instruments
Crossject Medical Technology
MIKA MEDICAL
Ferring Pharmaceuticals
D'Antonio Consultants International
Lepu Medical
TECHiJET
Segment by Power
Reusable Injector
Single-use Injector
Segment by Application
Vaccine Delivery
Insulin Delivery
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Needle-free Injection Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Needle-free Injection Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Power, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Needle-free Injection Systems 麻豆原创 Overview
1.1 Product Definition
1.2 Needle-free Injection Systems by Power
1.2.1 Global Needle-free Injection Systems 麻豆原创 Value Comparison by Power (2024 VS 2031)
1.2.2 Reusable Injector
1.2.3 Single-use Injector
1.3 Needle-free Injection Systems by Application
1.3.1 Global Needle-free Injection Systems 麻豆原创 Value by Application (2024 VS 2031)
1.3.2 Vaccine Delivery
1.3.3 Insulin Delivery
1.3.4 Others
1.4 Global Needle-free Injection Systems 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Needle-free Injection Systems Revenue 2020-2031
1.4.2 Global Needle-free Injection Systems Sales 2020-2031
1.4.3 Global Needle-free Injection Systems 麻豆原创 Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Needle-free Injection Systems 麻豆原创 Competition by Manufacturers
2.1 Global Needle-free Injection Systems Sales 麻豆原创 Share by Manufacturers (2020-2025)
2.2 Global Needle-free Injection Systems Revenue 麻豆原创 Share by Manufacturers (2020-2025)
2.3 Global Needle-free Injection Systems Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Needle-free Injection Systems, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Needle-free Injection Systems, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Needle-free Injection Systems, Product Type & Application
2.7 Global Key Manufacturers of Needle-free Injection Systems, Date of Enter into This Industry
2.8 Global Needle-free Injection Systems 麻豆原创 Competitive Situation and Trends
2.8.1 Global Needle-free Injection Systems 麻豆原创 Concentration Rate
2.8.2 The Global 5 and 10 Largest Needle-free Injection Systems Players 麻豆原创 Share by Revenue
2.8.3 Global Needle-free Injection Systems 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Needle-free Injection Systems 麻豆原创 Scenario by Region
3.1 Global Needle-free Injection Systems 麻豆原创 Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Needle-free Injection Systems Sales by Region: 2020-2031
3.2.1 Global Needle-free Injection Systems Sales by Region: 2020-2025
3.2.2 Global Needle-free Injection Systems Sales by Region: 2026-2031
3.3 Global Needle-free Injection Systems Revenue by Region: 2020-2031
3.3.1 Global Needle-free Injection Systems Revenue by Region: 2020-2025
3.3.2 Global Needle-free Injection Systems Revenue by Region: 2026-2031
3.4 North America Needle-free Injection Systems 麻豆原创 Facts & Figures by Country
3.4.1 North America Needle-free Injection Systems 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Needle-free Injection Systems Sales by Country (2020-2031)
3.4.3 North America Needle-free Injection Systems Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Needle-free Injection Systems 麻豆原创 Facts & Figures by Country
3.5.1 Europe Needle-free Injection Systems 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Needle-free Injection Systems Sales by Country (2020-2031)
3.5.3 Europe Needle-free Injection Systems Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Needle-free Injection Systems 麻豆原创 Facts & Figures by Region
3.6.1 Asia Pacific Needle-free Injection Systems 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Needle-free Injection Systems Sales by Region (2020-2031)
3.6.3 Asia Pacific Needle-free Injection Systems Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Needle-free Injection Systems 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Needle-free Injection Systems 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Needle-free Injection Systems Sales by Country (2020-2031)
3.7.3 Latin America Needle-free Injection Systems Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Needle-free Injection Systems 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Needle-free Injection Systems 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Needle-free Injection Systems Sales by Country (2020-2031)
3.8.3 Middle East and Africa Needle-free Injection Systems Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Power
4.1 Global Needle-free Injection Systems Sales by Power (2020-2031)
4.1.1 Global Needle-free Injection Systems Sales by Power (2020-2025)
4.1.2 Global Needle-free Injection Systems Sales by Power (2026-2031)
4.1.3 Global Needle-free Injection Systems Sales 麻豆原创 Share by Power (2020-2031)
4.2 Global Needle-free Injection Systems Revenue by Power (2020-2031)
4.2.1 Global Needle-free Injection Systems Revenue by Power (2020-2025)
4.2.2 Global Needle-free Injection Systems Revenue by Power (2026-2031)
4.2.3 Global Needle-free Injection Systems Revenue 麻豆原创 Share by Power (2020-2031)
4.3 Global Needle-free Injection Systems Price by Power (2020-2031)
5 Segment by Application
5.1 Global Needle-free Injection Systems Sales by Application (2020-2031)
5.1.1 Global Needle-free Injection Systems Sales by Application (2020-2025)
5.1.2 Global Needle-free Injection Systems Sales by Application (2026-2031)
5.1.3 Global Needle-free Injection Systems Sales 麻豆原创 Share by Application (2020-2031)
5.2 Global Needle-free Injection Systems Revenue by Application (2020-2031)
5.2.1 Global Needle-free Injection Systems Revenue by Application (2020-2025)
5.2.2 Global Needle-free Injection Systems Revenue by Application (2026-2031)
5.2.3 Global Needle-free Injection Systems Revenue 麻豆原创 Share by Application (2020-2031)
5.3 Global Needle-free Injection Systems Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Antares Pharma
6.1.1 Antares Pharma Company Information
6.1.2 Antares Pharma Description and Business Overview
6.1.3 Antares Pharma Needle-free Injection Systems Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Antares Pharma Needle-free Injection Systems Product Portfolio
6.1.5 Antares Pharma Recent Developments/Updates
6.2 Endo International plc
6.2.1 Endo International plc Company Information
6.2.2 Endo International plc Description and Business Overview
6.2.3 Endo International plc Needle-free Injection Systems Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Endo International plc Needle-free Injection Systems Product Portfolio
6.2.5 Endo International plc Recent Developments/Updates
6.3 Inovio Pharmaceuticals
6.3.1 Inovio Pharmaceuticals Company Information
6.3.2 Inovio Pharmaceuticals Description and Business Overview
6.3.3 Inovio Pharmaceuticals Needle-free Injection Systems Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Inovio Pharmaceuticals Needle-free Injection Systems Product Portfolio
6.3.5 Inovio Pharmaceuticals Recent Developments/Updates
6.4 Injex Pharma
6.4.1 Injex Pharma Company Information
6.4.2 Injex Pharma Description and Business Overview
6.4.3 Injex Pharma Needle-free Injection Systems Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Injex Pharma Needle-free Injection Systems Product Portfolio
6.4.5 Injex Pharma Recent Developments/Updates
6.5 National Medical Products Inc (J-Tip)
6.5.1 National Medical Products Inc (J-Tip) Company Information
6.5.2 National Medical Products Inc (J-Tip) Description and Business Overview
6.5.3 National Medical Products Inc (J-Tip) Needle-free Injection Systems Sales, Revenue and Gross Margin (2020-2025)
6.5.4 National Medical Products Inc (J-Tip) Needle-free Injection Systems Product Portfolio
6.5.5 National Medical Products Inc (J-Tip) Recent Developments/Updates
6.6 Recipharm
6.6.1 Recipharm Company Information
6.6.2 Recipharm Description and Business Overview
6.6.3 Recipharm Needle-free Injection Systems Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Recipharm Needle-free Injection Systems Product Portfolio
6.6.5 Recipharm Recent Developments/Updates
6.7 European Pharma Group (InsuJet)
6.7.1 European Pharma Group (InsuJet) Company Information
6.7.2 European Pharma Group (InsuJet) Description and Business Overview
6.7.3 European Pharma Group (InsuJet) Needle-free Injection Systems Sales, Revenue and Gross Margin (2020-2025)
6.7.4 European Pharma Group (InsuJet) Needle-free Injection Systems Product Portfolio
6.7.5 European Pharma Group (InsuJet) Recent Developments/Updates
6.8 Miracle Medical
6.8.1 Miracle Medical Company Information
6.8.2 Miracle Medical Description and Business Overview
6.8.3 Miracle Medical Needle-free Injection Systems Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Miracle Medical Needle-free Injection Systems Product Portfolio
6.8.5 Miracle Medical Recent Developments/Updates
6.9 Medical International Technology (MIT)
6.9.1 Medical International Technology (MIT) Company Information
6.9.2 Medical International Technology (MIT) Description and Business Overview
6.9.3 Medical International Technology (MIT) Needle-free Injection Systems Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Medical International Technology (MIT) Needle-free Injection Systems Product Portfolio
6.9.5 Medical International Technology (MIT) Recent Developments/Updates
6.10 Akra Dermojet
6.10.1 Akra Dermojet Company Information
6.10.2 Akra Dermojet Description and Business Overview
6.10.3 Akra Dermojet Needle-free Injection Systems Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Akra Dermojet Needle-free Injection Systems Product Portfolio
6.10.5 Akra Dermojet Recent Developments/Updates
6.11 PharmaJet
6.11.1 PharmaJet Company Information
6.11.2 PharmaJet Description and Business Overview
6.11.3 PharmaJet Needle-free Injection Systems Sales, Revenue and Gross Margin (2020-2025)
6.11.4 PharmaJet Needle-free Injection Systems Product Portfolio
6.11.5 PharmaJet Recent Developments/Updates
6.12 Portal Instruments
6.12.1 Portal Instruments Company Information
6.12.2 Portal Instruments Description and Business Overview
6.12.3 Portal Instruments Needle-free Injection Systems Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Portal Instruments Needle-free Injection Systems Product Portfolio
6.12.5 Portal Instruments Recent Developments/Updates
6.13 Crossject Medical Technology
6.13.1 Crossject Medical Technology Company Information
6.13.2 Crossject Medical Technology Description and Business Overview
6.13.3 Crossject Medical Technology Needle-free Injection Systems Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Crossject Medical Technology Needle-free Injection Systems Product Portfolio
6.13.5 Crossject Medical Technology Recent Developments/Updates
6.14 MIKA MEDICAL
6.14.1 MIKA MEDICAL Company Information
6.14.2 MIKA MEDICAL Description and Business Overview
6.14.3 MIKA MEDICAL Needle-free Injection Systems Sales, Revenue and Gross Margin (2020-2025)
6.14.4 MIKA MEDICAL Needle-free Injection Systems Product Portfolio
6.14.5 MIKA MEDICAL Recent Developments/Updates
6.15 Ferring Pharmaceuticals
6.15.1 Ferring Pharmaceuticals Company Information
6.15.2 Ferring Pharmaceuticals Description and Business Overview
6.15.3 Ferring Pharmaceuticals Needle-free Injection Systems Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Ferring Pharmaceuticals Needle-free Injection Systems Product Portfolio
6.15.5 Ferring Pharmaceuticals Recent Developments/Updates
6.16 D'Antonio Consultants International
6.16.1 D'Antonio Consultants International Company Information
6.16.2 D'Antonio Consultants International Description and Business Overview
6.16.3 D'Antonio Consultants International Needle-free Injection Systems Sales, Revenue and Gross Margin (2020-2025)
6.16.4 D'Antonio Consultants International Needle-free Injection Systems Product Portfolio
6.16.5 D'Antonio Consultants International Recent Developments/Updates
6.17 Lepu Medical
6.17.1 Lepu Medical Company Information
6.17.2 Lepu Medical Description and Business Overview
6.17.3 Lepu Medical Needle-free Injection Systems Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Lepu Medical Needle-free Injection Systems Product Portfolio
6.17.5 Lepu Medical Recent Developments/Updates
6.18 TECHiJET
6.18.1 TECHiJET Company Information
6.18.2 TECHiJET Description and Business Overview
6.18.3 TECHiJET Needle-free Injection Systems Sales, Revenue and Gross Margin (2020-2025)
6.18.4 TECHiJET Needle-free Injection Systems Product Portfolio
6.18.5 TECHiJET Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Needle-free Injection Systems Industry Chain Analysis
7.2 Needle-free Injection Systems Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Needle-free Injection Systems Production Mode & Process Analysis
7.4 Needle-free Injection Systems Sales and 麻豆原创ing
7.4.1 Needle-free Injection Systems Sales Channels
7.4.2 Needle-free Injection Systems Distributors
7.5 Needle-free Injection Systems Customer Analysis
8 Needle-free Injection Systems 麻豆原创 Dynamics
8.1 Needle-free Injection Systems Industry Trends
8.2 Needle-free Injection Systems 麻豆原创 Drivers
8.3 Needle-free Injection Systems 麻豆原创 Challenges
8.4 Needle-free Injection Systems 麻豆原创 Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Antares Pharma
Endo International plc
Inovio Pharmaceuticals
Injex Pharma
National Medical Products Inc (J-Tip)
Recipharm
European Pharma Group (InsuJet)
Miracle Medical
Medical International Technology (MIT)
Akra Dermojet
PharmaJet
Portal Instruments
Crossject Medical Technology
MIKA MEDICAL
Ferring Pharmaceuticals
D'Antonio Consultants International
Lepu Medical
TECHiJET
听
听
*If Applicable.
